Blood and Fluid Warming Medical Devices - Market Insights, Competitive Landscape and Market Forecast-2027

Blood and Fluid Warming Medical Devices - Market Insights, Competitive Landscape and Market Forecast-2027

Blood and Fluid Warming Medical Devices By System Type (Intravenous Warming System, Patient Warming System, And Surface Warming System), By Portability (Portable And Non-Portable), By Application (New Born Care, Pre-Operative Care, Acute Care, Homecare, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2027 owing to the increasing number of hypothermia cases and the increasing number of geriatric and infant population

The global blood and fluid warming medical devices is expected to grow at a CAGR of 6.49% during the forecast period from 2022 to 2027. The blood and fluid warming medical devices is witnessing positive growth owing to various factors such as rising cases of hypothermia, the escalating burden of geriatric and infant’s population, surging number of hospital admissions, surgeries and trauma cases, and the rising cases of chronic diseases requiring blood transfusion across the globe. Therefore, the market for blood and fluid warming devices is estimated to grow at a significant CAGR during the forecast period from 2022 to 2027.

Blood and Fluid Warming Medical Devices Dynamics:

One of the main drivers of the blood and fluid warming medical devices is the increasing figure of surgeries & trauma cases due to the increasing prevalence of chronic disorders such as cardiovascular, cancers, urological, neurological, among others.

For instance, as per the GLOBOCAN data 2020, the bladder cancer burden has increased to 19.3 million cases in the year 2020 and bladder cancer is the tenth most frequent cancer worldwide. According to the source mentioned above, 573,278 people worldwide were diagnosed with bladder cancer in the year 2020. Moreover, as per the same source, the incidence rate of breast cancer was reported to be 47.6%, globally, in the year 2020. In the same way the prevalence of cancers are increasing day by day and is expected to increase in the similar manner in the upcoming years. Cancer are usually treated with some surgical procedures where the tumour is removed from the body. Usually most of the surgical procedures require blood and fluid transfusion. During this process, blood is sometime warmed using the blood and fluid warming devices. Thus, the increasing prevalence of different type cancers will increase the number of surgical procedures, thereby increasing the demand of blood and fluid warming devices, required during blood transfusion.

Another factor which will drive the demand of blood and fluid warming devices is the increasing cases of hypothermia across the globe. The major causative factor for hypothermia are nerve function dysfunction, drug intoxication, and environmental exposure. According to the Centers for Disease Prevention and Control (CDC), 2021, nearly 1,000 deaths occur every year in the United States due to hypothermia. The mortality rate can be reduced by ensuring a proper body and blood temperature using blood and fluid warming devices. Thus, the increasing cases of hypothermia will increase the demand of blood and fluid warming devices in the forthcoming years.

Therefore, the factors stated above collectively will drive the overall blood and fluid warming medical devices during the forecast period from 2022-2027.

However, the less awareness of blood and fluid warming devices, stringent regulatory approval process and others, can hamper the global blood and fluid warming medical devices growth.

The COVID-19 epidemic has significantly impacted the blood and fluid warming devices market. The nationwide lockdown in almost every country-restricted people's movement & hospital visits, halted supply chains & logistics, hampered the manufacturing process, resulting in a product shortage in the market, and elective surgeries and blood transfusion process were also halted and were not on priority because COVID-19 patients were given priority in terms of treatment. However, the hospital admissions of the patients suffering from COVID-19 was increased. High fever and shivering was one of the basic symptoms of patients who may be suffering from COVID-19. As a result, use of warm blankets and sterile fluids increased due to the increasing number of patients in hospitals and clinics, this is in turn can be expected to propel industry growth. Moreover, with the masses being vaccinated, relaxation in lockdown restrictions, resumption of supply chains, logistics, manufacturing units, increase in elective surgeries for the treatment of chronic diseases and trauma, and the increasing demand of warming devices for COVID-19 patients, the blood and fluid warming devices demand increased and is expected to further grow during the forecast period.

Blood and Fluid Warming Medical Devices Segment Analysis:

Blood and Fluid Warming Medical Devices By System Type (Intravenous Warming System, Patient Warming System, and Surface Warming System), Portability (Portable and Non-Portable), Application (New Born Care, Pre-Operative Care, Acute Care, Homecare, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the system type segment of the blood and fluid warming medical devices, the surface warming system market is expected to have a significant revenue share in the year 2021. This was primarily owing to the increasing cases of surgeries and trauma or accidents across the globe. Surface warming systems are usually used during the perioperative process, thereby the increasing number of surgeries due to some trauma or accidents will be responsible for the growth of the device.

According to the Transport Canada’s National Collision Database (NCDB) 2022, nearly 7,868 serious or severe injuries were reported due to some accidents in the year 2020, in Canada. As per the same source, the number of total injuries were reported to be 101,572 in 2020, in Canada.

Moreover, according to the Transport Research Wing 2020, a total number of 3,66,138 road accidents have been reported by States and Union Territories (UTs) during the calendar year 2020, claiming 1,31,714 lives and causing serious injuries to 3,48,279 people. These injuries might require a surgical procedure for its treatment, ultimately increasing the number of surgical procedures. The increase in surgical procedures will increase the demand of surface warming system, a blood and fluid warming device used by surgeons during the perioperative process.

Moreover, due to the interplay of all the factors mentioned above, this can result in the rising demand for surface warming blood and fluid warming devices, which in turn would provide a conducive growth environment for overall blood and fluid warming devices during the market forecast 2022-2027.

North America is expected to dominate the overall Blood and Fluid Warming Medical Devices:

Among all the regions, North America is expected to dominate the global blood and fluid warming medical devices in the year 2021 and is expected to do the same during the forecast period of 2022-2027. Factors such as the increasing number of trauma & surgery in the region, rising prevalence of chronic disorders & cancers, and the rise in the regulatory approvals for blood and fluid warming devices will increase the demand for blood and fluid warming devices in the North America market.

According to the American Cancer Society (2022), in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. The treatment and management of cancers might require a surgical procedure in which the tumor is removed. Surgeries always require blood transfusion and prior to the blood transfusion the temperature of the blood should be optimum so as to avoid any complications. In order to achieve, an ideal blood temperature a blood and fluid warming devices are used, thereby increasing its demand in the market. Thus, the increasing prevalence of cancer will increase the number of surgery and blood transfusion, therefore increasing the demand of blood and transfusion devices used to achieve proper blood temperature during the transfusion process.

Additionally, the surge in number of surgical procedure owing to a rise in the number of trauma or accidents cases in the region will spur the market of blood and fluid warming devices. As per the data concluded by US Bureau of Labor Statistics 2021, there were approximately 4,764 fatal work injuries recorded in the United States in 2020. The work injuries will require some short of surgical procedure, which will require blood transfusion and blood and fluid warming devices.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the blood and fluid warming medical devices.

Blood and Fluid Warming Medical Devices Key Players:

Some of the key market players operating in the blood and fluid warming medical devices include General Electric Company, ICU Medical, Inc., BD, Boston Scientific Corporation, 3M, Barkey, SINO MDT, EMIT CORPORATION, Weiss Technik North America, Inc., Stihler Electronic GmbH, Biegler GmbH, Belmont Medical Technologies, Stryker, GENTHERM., Vyaire Medical, Inc, The Surgical Company., Life Warmer, MEQU, Blue Neem Medical Devices Pvt Ltd, ACE Medical Devices Pvt. Ltd, and others.

Recent Developmental Activities in the Blood and Fluid Warming Medical Devices:

In April 2021, MEQU, Danish medtech company, had launched an in-hospital solution, °M Station, for its blood and IV fluid warming device, °M Warmer System. M Warmer System is a portable blood and IV fluid warming device that is adopted in the pre-hospital and military sectors.

In January 2019, Life Warmer, Inc., received 510 (k) approval for the marketing of the Quantum Blood and IV Fluid Infusion Warmer.

Key Takeaways from the Blood and Fluid Warming Medical Devices Report Study

Market size analysis for current blood and fluid warming medical devices (2021), and market forecast for 5 years (2022-2027)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the blood and fluid warming medical devices

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years

Key companies dominating the global blood and fluid warming medical devices

Various opportunities are available for the other competitor in the blood and fluid warming medical devices space.

What are the top-performing segments in 2021? How these segments will perform in 2027.

Which are the top-performing regions and countries in the current blood and fluid warming medical devices scenario?

Which are the regions and countries where companies should have concentrated on opportunities for blood and fluid warming medical devices growth in the coming future?

Target Audience who can be benefited from this Blood and Fluid Warming Medical Devices Report Study

Blood and fluid warming medical devices providers

Research organizations and consulting companies

Blood and fluid warming medical devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and traders dealing in blood and fluid warming medical devices

Various end-users who want to know more about the blood and fluid warming medical devices and the latest technological developments in the blood and fluid warming medical devices

Frequently Asked Questions for Blood And Fluid Warming Medical Devices:

1. What are Blood and Fluid Warming Medical Devices?

A blood warmer, is a medical devices used to warm blood or other fluids, minimizing the risk of hypothermia. On the other hand, a fluid warming device, is a medical devices used in healthcare facilities for warming fluids, crystalloid, colloid, or blood product, prior to being administered to body temperature levels in order to prevent hypothermia in physically traumatized or surgical patients.

2. What is the market for Global Blood and Fluid Warming Medical Devices?

The global blood and fluid warming medical devices is expected to grow at a CAGR of 6.49% during the forecast period from 2022 to 2027.

3. What are the drivers for the Global Blood and Fluid Warming Medical Devices?

The blood and fluid warming medical devices is witnessing a positive market growth owing to the factors such as the rising cases of hypothermia, the escalating burden of geriatric and infants population, surging number of hospital admissions, surgeries and trauma cases, and the rising cases of chronic diseases requiring blood transfusion, and the rise in the regulatory approvals for blood and fluid warming devices.

4. Who are the key players operating in the Blood and Fluid Warming Medical Devices?

Some of the key market players operating in the blood and fluid warming medical devices include General Electric Company, ICU Medical, Inc., BD, Boston Scientific Corporation, 3M, Barkey, SINO MDT, EMIT CORPORATION, Weiss Technik North America, Inc., Stihler Electronic GmbH, Biegler GmbH, Belmont Medical Technologies, Stryker, GENTHERM., Vyaire Medical, Inc, The Surgical Company., Life Warmer, MEQU, Blue Neem Medical Devices Pvt Ltd, ACE Medical Devices Pvt. Ltd, and others

5. Which region has the highest share in Blood and Fluid Warming Medical Devices?

North America is expected to dominate the global blood and fluid warming medical devices. Factors contributing to the growth are the increasing prevalence of surgeries, hospitals admissions, and trauma cases, the rising number of chronic disorders, and the rise in the regulatory approvals for blood and fluid warming medical devices, which are contributing to the growth of the blood and fluid warming medical devices in the North America region.

Please Note: It will take 7-10 business days to complete the report upon order confirmation.